Influenza

Safety and Efficacy: IV Zanamivir vs Oral Oseltamivir in Severe Influenza

By

Cindy Lampner

Intravenous zanamivir is as safe and effective as oral oseltamivir when used in patients with severe influenza.

Influenza Vaccine for Older Adults Granted Fast Track Status

By

Steve Duffy

The Food and Drug Administration has granted Fast Track designation to NanoFlu (Novavax) for seasonal influenza vaccination in adults ≥65 years.

Oseltamivir Reduces Recovery Time for Influenza-Like Illness in European Study

By

Rita Aghjayan

Oseltamivir may reduce recovery time for primary care patients with influenza-like illness, especially for older, sicker patients with comorbidities.

CDC: Influenza Season on Similar Trajectory as Worst Recent Years

The most unusual part of this flu season is that the influenza B strain has been more prevalent than influenza A.

Novel Avian Influenza Vaccine Is Safe and Immunogenic

By

Pulmonology Advisor Contributing Writer

A new vaccine for the avian influenza A(H5N1) was shown to be safe and immunogenic.

CDC: Influenza Cases Continue to Elevate Across the United States

The CDC says it is still too early to know how severe this year’s influenza season will be.

No Association Between Influenza Severity and Pediatric Vaccination Rate

By

Zahra Masoud

Vaccine effectiveness and severity of current and prior seasons of influenza have demonstrated no association with vaccination rate in children, according to a study published in JAMA Pediatrics. Compared with other pediatric and adolescent vaccines, the influenza vaccination rate remains low in children. Although many reasons may affect whether a child is vaccinated, the extent…

Heterogeneous Sex Differences in the Immunogenicity, Effectiveness of Influenza Vaccine

By

Pulmonology Advisor Contributing Writer

Evidence of higher quality is needed to better understand sex differences in response to influenza vaccine.

Influenza Vaccination Required at Few Child Care Centers

Having a requirement for child influenza vaccine was the only predictor of having an adult vaccine requirement.